151 related articles for article (PubMed ID: 33751882)
1. Mannose-Functionalized Biodegradable Nanoparticles Efficiently Deliver DNA Vaccine and Promote Anti-tumor Immunity.
Sun B; Zhao X; Wu Y; Cao P; Movahedi F; Liu J; Wang J; Xu ZP; Gu W
ACS Appl Mater Interfaces; 2021 Mar; 13(12):14015-14027. PubMed ID: 33751882
[TBL] [Abstract][Full Text] [Related]
2. Intranasal immunization with poly(γ-glutamic acid) nanoparticles entrapping antigenic proteins can induce potent tumor immunity.
Matsuo K; Koizumi H; Akashi M; Nakagawa S; Fujita T; Yamamoto A; Okada N
J Control Release; 2011 Jun; 152(2):310-6. PubMed ID: 21402114
[TBL] [Abstract][Full Text] [Related]
3. Targeted antigen delivery to dendritic cell via functionalized alginate nanoparticles for cancer immunotherapy.
Zhang C; Shi G; Zhang J; Song H; Niu J; Shi S; Huang P; Wang Y; Wang W; Li C; Kong D
J Control Release; 2017 Jun; 256():170-181. PubMed ID: 28414151
[TBL] [Abstract][Full Text] [Related]
4. ATP stabilised and sensitised calcium phosphate nanoparticles as effective adjuvants for a DNA vaccine against cancer.
Sun B; Zhao X; Gu W; Cao P; Movahedi F; Wu Y; Xu ZP; Gu W
J Mater Chem B; 2021 Sep; 9(36):7435-7446. PubMed ID: 34551058
[TBL] [Abstract][Full Text] [Related]
5. Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine.
Shi GN; Zhang CN; Xu R; Niu JF; Song HJ; Zhang XY; Wang WW; Wang YM; Li C; Wei XQ; Kong DL
Biomaterials; 2017 Jan; 113():191-202. PubMed ID: 27816821
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis.
Xu Z; Ramishetti S; Tseng YC; Guo S; Wang Y; Huang L
J Control Release; 2013 Nov; 172(1):259-265. PubMed ID: 24004885
[TBL] [Abstract][Full Text] [Related]
7. Smart pH-Responsive Nanocube-Controlled Delivery of DNA Vaccine and Chemotherapeutic Drugs for Chemoimmunotherapy.
Duong HTT; Thambi T; Yin Y; Lee JE; Seo YK; Jeong JH; Lee DS
ACS Appl Mater Interfaces; 2019 Apr; 11(14):13058-13068. PubMed ID: 30888149
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticles built by self-assembly of amphiphilic gamma-PGA can deliver antigens to antigen-presenting cells with high efficiency: a new tumor-vaccine carrier for eliciting effector T cells.
Yoshikawa T; Okada N; Oda A; Matsuo K; Matsuo K; Kayamuro H; Ishii Y; Yoshinaga T; Akagi T; Akashi M; Nakagawa S
Vaccine; 2008 Mar; 26(10):1303-13. PubMed ID: 18255205
[TBL] [Abstract][Full Text] [Related]
9. Mannose-functionalized antigen nanoparticles for targeted dendritic cells, accelerated endosomal escape and enhanced MHC-I antigen presentation.
Pei M; Xu R; Zhang C; Wang X; Li C; Hu Y
Colloids Surf B Biointerfaces; 2021 Jan; 197():111378. PubMed ID: 33010719
[TBL] [Abstract][Full Text] [Related]
10. Mannosylated protamine as a novel DNA vaccine carrier for effective induction of anti-tumor immune responses.
Zeng Z; Dai S; Jiao Y; Jiang L; Zhao Y; Wang B; Zong L
Int J Pharm; 2016 Jun; 506(1-2):394-406. PubMed ID: 27106528
[TBL] [Abstract][Full Text] [Related]
11. Smart vaccine delivery based on microneedle arrays decorated with ultra-pH-responsive copolymers for cancer immunotherapy.
Duong HTT; Yin Y; Thambi T; Nguyen TL; Giang Phan VH; Lee MS; Lee JE; Kim J; Jeong JH; Lee DS
Biomaterials; 2018 Dec; 185():13-24. PubMed ID: 30216806
[TBL] [Abstract][Full Text] [Related]
12. Glycosylation of OVA antigen-loaded PLGA nanoparticles enhances DC-targeting for cancer vaccination.
Chou PY; Lin SY; Wu YN; Shen CY; Sheu MT; Ho HO
J Control Release; 2022 Nov; 351():970-988. PubMed ID: 36220488
[TBL] [Abstract][Full Text] [Related]
13. In vivo delivery of peptides and Toll-like receptor ligands by mannose-functionalized polymeric nanoparticles induces prophylactic and therapeutic anti-tumor immune responses in a melanoma model.
Silva JM; Zupancic E; Vandermeulen G; Oliveira VG; Salgado A; Videira M; Gaspar M; Graca L; Préat V; Florindo HF
J Control Release; 2015 Jan; 198():91-103. PubMed ID: 25483429
[TBL] [Abstract][Full Text] [Related]
14. Enhanced DNA vaccine potency by mannosylated lipoplex after intraperitoneal administration.
Hattori Y; Kawakami S; Lu Y; Nakamura K; Yamashita F; Hashida M
J Gene Med; 2006 Jul; 8(7):824-34. PubMed ID: 16625665
[TBL] [Abstract][Full Text] [Related]
15. Metal-Phenolic Network-Encapsulated Nanovaccine with pH and Reduction Dual Responsiveness for Enhanced Cancer Immunotherapy.
Zhou X; Su Q; Zhao H; Cao X; Yang Y; Xue W
Mol Pharm; 2020 Dec; 17(12):4603-4615. PubMed ID: 33175556
[TBL] [Abstract][Full Text] [Related]
16. Construction of lymph nodes-targeting tumor vaccines by using the principle of DNA base complementary pairing to enhance anti-tumor cellular immune response.
Zha Y; Fu L; Liu Z; Lin J; Huang L
J Nanobiotechnology; 2024 May; 22(1):230. PubMed ID: 38720322
[TBL] [Abstract][Full Text] [Related]
17. Targeted Codelivery of an Antigen and Dual Agonists by Hybrid Nanoparticles for Enhanced Cancer Immunotherapy.
Zhang L; Wu S; Qin Y; Fan F; Zhang Z; Huang C; Ji W; Lu L; Wang C; Sun H; Leng X; Kong D; Zhu D
Nano Lett; 2019 Jul; 19(7):4237-4249. PubMed ID: 30868883
[TBL] [Abstract][Full Text] [Related]
18. Feasibility study of novel nanoparticles derived from
Suzuki Y; Munakata L; Omata D; Koizumi K; Suzuki R
Immunotherapy; 2022 Dec; 14(18):1443-1455. PubMed ID: 36597713
[No Abstract] [Full Text] [Related]
19. Enhanced Spacer Length between Mannose Mimicking Shikimoyl and Quinoyl Headgroups and Hydrophobic Region of Cationic Amphiphile Increases Efficiency of Dendritic Cell Based DNA Vaccination: A Structure-Activity Investigation.
Voshavar C; Meka RC; Samanta S; Marepally S; Chaudhuri A
J Med Chem; 2017 Feb; 60(4):1605-1610. PubMed ID: 28124909
[TBL] [Abstract][Full Text] [Related]
20. Development of an ultrasound-responsive and mannose-modified gene carrier for DNA vaccine therapy.
Un K; Kawakami S; Suzuki R; Maruyama K; Yamashita F; Hashida M
Biomaterials; 2010 Oct; 31(30):7813-26. PubMed ID: 20656348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
